Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study-Reference-Cited by-同舟云学术

Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study

Published:2019-04-08 Issue:6 Volume:83 Page:1091-1097
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Araz Murat^ORCID,Karaagac Mustafa,Korkmaz Levent,Koral Lokman,Inci Fatih,Beypinar Ismail,Uysal Mukremin,Artac Mehmet

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-019-03831-4.pdf

Reference20 articles.

1. Longo DL, Navari RM, Aapro M (2016) Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J Med 374(14):1356–1367. https://doi.org/10.1056/NEJMra1515442

2. Vieira L, Souza FH, Brunetto AT, Sasse AD, Paulo J, Lima N (2012) Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review. J Natl Cancer Inst 104:1280–1292. https://doi.org/10.1093/jnci/djs335

3. Jordan K, Hinke A, Grothey A, Voigt W, Arnold D, Wolf H (2007) A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis. Support Care Cancer 15:1023–1033. https://doi.org/10.1007/s00520-006-0186-7

4. Lau TKH, Yip CHW, Yeo W (2016) State of the art antiemetic therapy for cancer patients. Curr Oncol Rep 18(1):1–13. https://doi.org/10.1007/s11912-015-0486-5

5. Navari RM (2014) Palonosetron for the treatment of chemotherapy-induced nausea and vomiting. Expert Opin Pharmacother 15(17):2599–2608

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy;Journal of Oncology Pharmacy Practice;2024-08-28

2. Differences in severity of chemotherapy-induced nausea and vomiting between neoadjuvant and adjuvant chemotherapy in patients with breast cancer: analysis of data from two prospective observational studies;Supportive Care in Cancer;2024-07-13

3. Effect of Selective 5-Hydroxytryptamine-3 Receptor and Neurokinin-1 Receptor Antagonists on Hemodynamic Changes and Arrhythmogenic Potential in Patients Receiving Chemotherapy: A Retrospective, Observational Study;Journal of Clinical Medicine;2024-02-01

4. Assessment of the change of antiemetic prophylaxis from double to triple combination in patients with high dose carboplatin chemotherapy;Journal of Oncology Pharmacy Practice;2023-08-10

5. Assessment of the Change of Antiemetic Prophylaxis From a Double Combination to a Triple Combination in Oncology Patients With High Dose Carboplatin Chemotherapy;2022-12-15